GenMed.care offers various Blood Tests for Cancer Screening
GenMed.care helps you to early discover cancer risks and, in the worst case, helps you to start fighting cancer with dendritic cell cancer therapy.
EDIM – Blood Test
In 1924 Otto Warburg won the Nobel Prize for the discovery that cancer cells get their energy from fermentation, despite the presence of oxygen. This is commonly known as aerobic glycolysis or the Warburg effect. Cancer researcher Dr. Johannes Coy eventually discovered the trigger of the Warburg effect to be the TKZL1 (TransketolaseLike1) enzyme. This is also the basis of the EDIM (EpitopDetektionInMonozyten) test. Depending on the energy obtained, one distinguishes between TKTL1 positive and TKTL1 negative cancer cells. With the negative cancer cells, the energy of the mitochondria is obtained with oxygen. With the positive cancer cells, a fermentation process takes place, which forms lactic acid. This lactic acid enables the cancer cells to be highly invasive and metastases to develop. Furthermore, the lactic acid inhibits the immune-response and how studies of the DKFZ (Deutsches Krebsforschungszentrum Heidelberg) have shown; TKTL1 cells are also less sensitive to radiation and chemotherapy.
AMAS – Blood Test
The AMAS- or AMA-test (Anti-Malignan Antibody) is a blood test to diagnose cancer early. The test was successful for almost all types of cancers, with a success rate of 95%, and even 99% when the test was repeated. The patent holder claims the error rate is less than 1%. The AMAS test is widely used in the US and also approved by the FDA as an early detection method for some cancers. A double-blind study with patients who have almost all types of cancer, and healthy patients, were able to verify the declared patents holder reliability. The test has been carried out for the past 21 years. Again, the benefits cannot be dismissed, just like the EDIM Test. Quick, inexpensive and reliable, the AMAS blood test is an additional help for a more accurate diagnosis and timely monitoring during therapy and during follow-up. Both tests can be carried out by GenMed.care.